Ang-(1-7) inhibited the cognitive deficits of mTBI, reduced neuronal loss, and reduced levels of phosphorylated Tau in the hippocampus during the secondary injury phase of mTBI. The gene discussed is MAPT; the disease is Cognitive impairment.